| Product NDC: | 0068-0226 |
| Proprietary Name: | Clomid |
| Non Proprietary Name: | clomiphene citrate |
| Active Ingredient(s): | 50 mg/1 & nbsp; clomiphene citrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0068-0226 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA016131 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19670201 |
| Package NDC: | 0068-0226-30 |
| Package Description: | 30 TABLET in 1 CARTON (0068-0226-30) |
| NDC Code | 0068-0226-30 |
| Proprietary Name | Clomid |
| Package Description | 30 TABLET in 1 CARTON (0068-0226-30) |
| Product NDC | 0068-0226 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clomiphene citrate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19670201 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | CLOMIPHENE CITRATE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] |